News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
228,244 Results
Type
Article (7174)
Company Profile (16)
Press Release (221054)
Multimedia
Podcasts (3)
Webinars (1)
Section
Business (63130)
Career Advice (295)
Deals (14769)
Drug Delivery (28)
Drug Development (36796)
Employer Resources (24)
FDA (6415)
Job Trends (4908)
News (121820)
Policy (11630)
Tag
2024 BioMidwest Digital (1)
2024 Biotech Bay Standard (1)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (1)
Academia (567)
Accelerated approval (2)
Adcomms (7)
Allergies (36)
Alliances (14775)
ALS (28)
Alzheimer's disease (601)
Antibody-drug conjugate (ADC) (42)
Approvals (6462)
Artificial intelligence (105)
Autoimmune disease (10)
Automation (3)
Bankruptcy (147)
Best Places to Work (4608)
BIOSECURE Act (2)
Biosimilars (21)
Biotechnology (18)
Bladder cancer (57)
Brain cancer (15)
Breast cancer (111)
Cancer (1185)
Cardiovascular disease (70)
Career advice (259)
Career pathing (4)
CAR-T (90)
Cell therapy (220)
Cervical cancer (12)
Clinical research (31226)
Collaboration (311)
Compensation (90)
Complete response letters (7)
COVID-19 (724)
CRISPR (18)
C-suite (78)
Cystic fibrosis (37)
Data (1346)
Denatured (1)
Depression (19)
Diabetes (111)
Diagnostics (2233)
Digital health (5)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (48)
Drug pricing (41)
Drug shortages (17)
Duchenne muscular dystrophy (40)
Earnings (33344)
Editorial (14)
Employer branding (1)
Employer resources (19)
Events (31116)
Executive appointments (250)
FDA (7097)
Featured Employer (3)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (270)
Gene editing (47)
Generative AI (10)
Gene therapy (133)
GLP-1 (185)
Government (1254)
Grass and pollen (2)
Guidances (40)
Healthcare (6139)
Huntington's disease (5)
IgA nephropathy (16)
Immunology and inflammation (36)
Indications (17)
Infectious disease (786)
Inflammatory bowel disease (61)
Inflation Reduction Act (5)
Influenza (24)
Intellectual property (54)
Interviews (45)
IPO (8034)
IRA (17)
Job creations (571)
Job search strategy (221)
Kidney cancer (8)
Labor market (5)
Layoffs (40)
Leadership (4)
Legal (2100)
Liver cancer (41)
Lung cancer (166)
Lymphoma (85)
Machine learning (2)
Management (7)
Manufacturing (106)
MASH (38)
Medical device (4587)
Medtech (4588)
Mergers & acquisitions (7094)
Metabolic disorders (282)
Multiple sclerosis (41)
NASH (8)
Neurodegenerative disease (25)
Neuropsychiatric disorders (4)
Neuroscience (813)
NextGen: Class of 2025 (1499)
Non-profit (712)
Northern California (1294)
Obesity (138)
Opinion (76)
Ovarian cancer (54)
Pain (38)
Pancreatic cancer (48)
Parkinson's disease (67)
Partnered (5)
Patents (136)
Patient recruitment (64)
Peanut (17)
People (14542)
Pharmaceutical (8)
Pharmacy benefit managers (6)
Phase I (9967)
Phase II (13739)
Phase III (10302)
Pipeline (755)
Policy (34)
Postmarket research (796)
Preclinical (3662)
Press Release (9)
Prostate cancer (53)
Psychedelics (11)
Radiopharmaceuticals (119)
Rare diseases (158)
Real estate (1004)
Recruiting (7)
Regulatory (9166)
Reports (13)
Research institute (510)
Resumes & cover letters (39)
Rett syndrome (4)
RNA editing (2)
RSV (16)
Schizophrenia (28)
Series A (44)
Series B (31)
Service/supplier (2)
Sickle cell disease (23)
Southern California (1127)
Special edition (2)
Spinal muscular atrophy (31)
Sponsored (14)
Startups (675)
Stomach cancer (5)
Supply chain (26)
Tariffs (3)
The Weekly (1)
United States (10773)
Vaccines (169)
Venture capitalists (5)
Weight loss (76)
Women's health (6)
Worklife (4)
Date
Today (44)
Last 7 days (394)
Last 30 days (1167)
Last 365 days (15794)
2025 (4920)
2024 (16924)
2023 (19103)
2022 (22236)
2021 (23634)
2020 (21800)
2019 (14442)
2018 (10640)
2017 (11455)
2016 (9542)
2015 (11738)
2014 (8102)
2013 (5877)
2012 (6040)
2011 (6751)
2010 (6216)
Location
Africa (176)
Alabama (16)
Alaska (2)
Arizona (55)
Arkansas (3)
Asia (17573)
Australia (4856)
California (2923)
Canada (1137)
China (247)
Colorado (123)
Connecticut (166)
Delaware (61)
Europe (28021)
Florida (432)
Georgia (68)
Idaho (6)
Illinois (211)
India (20)
Indiana (123)
Japan (91)
Kansas (14)
Kentucky (5)
Louisiana (5)
Maine (36)
Maryland (356)
Massachusetts (2087)
Michigan (51)
Minnesota (104)
Missouri (36)
Montana (11)
Nebraska (8)
Nevada (41)
New Hampshire (36)
New Jersey (1010)
New Mexico (3)
New York (930)
North Carolina (394)
North Dakota (2)
Northern California (1294)
Ohio (64)
Oklahoma (1)
Oregon (7)
Pennsylvania (686)
Puerto Rico (7)
Rhode Island (8)
South America (302)
South Carolina (11)
Southern California (1127)
Tennessee (42)
Texas (442)
Utah (68)
Virginia (77)
Washington D.C. (17)
Washington State (344)
West Virginia (2)
Wisconsin (11)
228,244 Results for "bionomics limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Bionomics Limited Announces Private Placement of up to $70.0 Million
Bionomics Limited announced it has entered into a securities purchase agreement with an institutional accredited investor to purchase American Depository Shares and accompanying warrants in a three-tranche private placement.
May 31, 2024
·
7 min read
Press Releases
Bionomics Limited announces intention to re-domicile to the United States
October 1, 2024
·
9 min read
Genetown
Bionomics to Present at the 2024 BIO CEO & Investor Conference
Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company) today announced that it will be presenting at the 2024 BIO CEO & Investor Conference taking place February 26-27, 2024 in New York, NY.
February 22, 2024
·
3 min read
Genetown
Bionomics to Present at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
Bionomics Limited announced that Spyridon “Spyros” Papapetropoulos, M.D., PhD, President and Chief Executive Officer of Bionomics will be giving an oral presentation and presenting two posters about BNC210 as a potential treatment for social anxiety disorder and post-traumatic stress disorder at the 2024 American Society of Clinical Psychopharmacology Annual Meeting taking place May 28 – 31 in Miami Beach, Florida.
May 20, 2024
·
4 min read
Press Releases
Bionomics to Present at the 2024 CNS Summit
November 8, 2024
·
3 min read
Press Releases
Bionomics to Present at the 2024 American College of Neuropsychopharmacology Annual Meeting
December 4, 2024
·
4 min read
Genetown
Bionomics Provides a Review of 2023 and of 2024 Plans
Bionomics Limited, a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel modulators to treat patients suffering from serious central nervous system disorders with high unmet medical need, provided a 2023 review and its outlook for 2024.
January 22, 2024
·
8 min read
Drug Development
Bionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress Disorder
Bionomics Limited announced the release of the full dataset analysis from its Phase 2b ATTUNE trial in patients with post-traumatic stress disorder.
March 21, 2024
·
10 min read
Press Releases
Bionomics Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision
October 7, 2024
·
8 min read
Genetown
Bionomics to Present at Biotech Showcase™ 2024The Company will provide an update on its leading asset BNC210 and their partnership strategy
Bionomics Limited announced that it will be presenting at the Biotech Showcase™ 2024 taking place January 8-10 in San Francisco, California.
January 5, 2024
·
3 min read
1 of 22,825
Next
